Filter Results:
(48)
Show Results For
- All HBS Web
(257)
- News (48)
- Research (170)
- Events (1)
- Multimedia (3)
- Faculty Publications (61)
Show Results For
- All HBS Web
(257)
- News (48)
- Research (170)
- Events (1)
- Multimedia (3)
- Faculty Publications (61)
Page 1 of 48
Results →
Sort by
- 08 Jul 2019
- News
What the U.S. can learn from Germany on drug prices
- 11 Sep 2019
- News
Germany May Have the Answer for Reducing Drug Prices
- 15 Sep 2016
- News
Price of pharma innovation: Pro
- 17 May 2019
- News
Tackling high Rx prices
- 20 Aug 2021
- News
Business Groups Sue Over Healthcare Price Transparency Rule
- 22 Feb 2016
- News
The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist
- 01 Mar 2007
- News
Daniel Vasella
years” in a Financial Times poll of 4,000 executives. He recently spoke about the public policy and business challenges ahead. U.S. consumers complain loudly that prescription drugs cost too much. What’s your response? We have a... View Details
- 29 Oct 2015
- News
Options to Promote Competitive Generics Markets in the United States
- 20 Aug 2020
- News
The U.S. Needs an SEC for its Health Care System
- 15 Apr 2015
- News
Biogen, Danish company in patent spat worth billions
- 09 Jun 2015
- News
How Merck Is Trying to Keep Disrupters at Bay
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
ending up with huge medical bills we couldn’t pay.” Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug... View Details
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
will solve real problems, from climate change and hunger to obesity and menstrual pain. They envision a future in which biotechnologists work from a platform that enables them to develop effective drugs within months for any emerging... View Details
- 01 Dec 2019
- News
The Race Against Resistance
the hospital, which we can then use to price our drug appropriately,” Kimble says. Kimble and Triola also stress the importance of developing antibiotics that can be used both in a hospital setting and at... View Details
Keywords: Lisa Scanlon Mogolov
- 01 Mar 2016
- News
Off Script
top posts at Schering-Plough and Wyeth. Are there structural reforms that could be implemented in the drug industry to lower the market-driven price of drugs? Forcing pharma firms to invest in R&D a minimum... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on View Details
- 01 Dec 2004
- News
Finding a Balance
period, multinational pharmas reported a growth rate of only 1 percent.) The case outlines Hamied’s impact — for one, pressuring global pharmas to cut the price of AIDS drugs by exporting a low-cost... View Details